Fosinopril Sodium and Hydrochlorothiazide (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Fosinopril Sodium and Hydrochlorothiazide drug offered from Glenmark Pharmaceuticals Inc., USA. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Fosinopril Sodium and Hydrochlorothiazide |
| SUBSTANCE NAME: | FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-07-09 |
| END MARKETING DATE: | 0000-00-00 |
Fosinopril Sodium and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fosinopril Sodium and Hydrochlorothiazide from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2009-07-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-554_687c6dae-abd4-420c-a457-7150bc6a081b |
| PRODUCT NDC: | 68462-554 |
| APPLICATION NUMBER: | ANDA090228 |
Other FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
